* Included in Asking Price
In 2013, the CEO of this firm embarked on an innovative idea of bringing a clinical lab service close to the community. He started building labs in physicians' offices, at a cost that was less than outsourcing the procedures. The benefits also include much quicker turnaround time for the medical provider/s as well as the patient. He is also building individual reference labs. This investment is for each of the reference labs to be built.
As of March 2015, he already constructed 3 labs and another substantial lab is under construction. Projected revenue for each of the next 3 years for the reference labs increases dramatically from $1.1 million in 2017 to $1.9 million in 2018 to $2.7 million in 2018.
The CEO is responsible for licenses, compliance and testing using a turnkey operations approach. The doctors contract this firm to perform the following activities:
1. Operating the lab
2. Hiring lab personnel such as phlebotomist/s and lab technicians
3. Generating results of each sample
4. Performing general maintenance of lab equipment
Reference labs require supplies, such as re-agents. The amount and cost of supplies depend on the size of the POL. On an average, yearly cost of supplies per reference lab is about $xx,***. This firm is the wholesaler of supplies ordered by doctors.
Required Licenses: Business, State
|Competition:||Physician's office labs (POLs) require supplies, such as re-agents. The amount and cost of supplies depend on the size of the POL. On an average, yearly cost of supplies per POL is about $60,000. This firm is the wholesaler of supplies ordered by doctors.|
|Growth Potential:||Financial Objectives and Projections: the objectives of the business plan are:
1.To raise $1,850,000 to capitalize wholesale operations
2.To maximum purchase discounts and ensure collection of receivables on timely basis
3.To structure company so that it can support clinical consultation business in terms of ensuring supplies and reagents are available when needed.|
The plan is to build reference labs in each of the 50 states. This will allow faster service to health and other facilities.
Projections are to have at least 6 Reference Labs under construction and/or operational by end of 2017; 8 by 2018; and 11 by 2019. .
Projections are to have at least 10 POLs under construction and/or operational by end of 2015; 20 by 2016 and 40, by 2017. At a conservative average of $62,500 for supplies/reagents, consultation, EPC commissions and retainer per POL, gross margins for the company will be at $625 in the first year to $3.125 million at end of year 3.
The POLs are contracted by this firm to secure their supplies from the company. It is therefore a captive market
A savvy buyer will be able to take advantage of this firmâ€™s strong foundation of experience in lab service and construction.
The ideal buyer will be an individual or firm who has knowledge, interest or experience in the medical diagnostic industry and wants to turn it into a successful business model.|
|Seller Financing:||Investment Comments:
A) $1 Million for 15% of Bowtie Corporate or;
B) $100,000 for 1.5% of Bowtie|
|Sale Reason:||Reason for Investment: To capitalize wholesale lab operations.|
Seller Reference #LINDENJ001-N644
The information in this ad has been provided by the business seller or representative stated on this ad. BuyBusiness.com has no stake in the sale of this business, has not independently verified any of the information about the business, and assumes no responsibility for its accuracy or completeness. Please read our Terms of Service
before responding to any ad on our website.